Literature DB >> 12568302

Cyclic platelet and leukocyte count oscillation in chronic myelocytic leukemia regulated by the negative feedback of transforming growth factor beta.

Yasuo Hirayama1, Sumio Sakamaki, Yasushi Tsuji, Takuya Matsunaga, Yoshiro Niitsu.   

Abstract

We report a case of chronic myelocytic leukemia (CML) with cyclic oscillation of platelet and leukocyte counts and attempt to elucidate the oscillatory mechanism from the standpoint of cytokine regulation of hematopoiesis. A 57-year-old woman with a diagnosis of CML exhibited platelet and white blood cell (WBC) count fluctuations of a cyclic nature. The average duration of the cycles was about 8 weeks. The patient suffered from headache, fatigue, and malaise at the peak of the cycle. The peak thrombopoietin concentration in peripheral blood coincided with a period of decrease in platelet numbers. The change in transforming growth factor beta (TGF-beta) level paralleled that of the platelet numbers. A progenitor cell assay revealed the suppression of trilineage colony formation in the presence of plasma from the blood cell peak point, and this suppression was completely blocked when the plasma was incubated with an anti-TGF-beta antibody. From these findings, we concluded that the cyclic oscillation of the platelet, WBC, and reticulocyte counts had been induced by excess negative feedback to megakaryopoiesis by TGF-beta.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12568302     DOI: 10.1007/BF02982605

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  11 in total

1.  Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression.

Authors:  J J Letterio; A G Geiser; A B Kulkarni; H Dang; L Kong; T Nakabayashi; C L Mackall; R E Gress; A B Roberts
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

2.  Cyclic leucocytosis as evidence for retention of normal homoeostatic control in chronic granulocytic leukaemia.

Authors:  A A Morley; A G Baikie; D A Galton
Journal:  Lancet       Date:  1967-12-23       Impact factor: 79.321

3.  Spontaneous cyclic leukocytosis and thrombocytosis in chronic granulocytic leukemia.

Authors:  H Vodopick; E M Rupp; C L Edwards; F A Goswitz; J J Beauchamp
Journal:  N Engl J Med       Date:  1972-02-10       Impact factor: 91.245

4.  Cyclic leukocytosis in chronic myelogenous leukemia: new perspectives on pathogenesis and therapy.

Authors:  R A Gatti; W A Robinson; A S Deinard; M Nesbit; J J McCullough; M Ballow; R A Good
Journal:  Blood       Date:  1973-06       Impact factor: 22.113

5.  Cyclic leukocyte oscillations in chronic myelogenous leukemia during hydroxyurea therapy.

Authors:  B J Kennedy
Journal:  Blood       Date:  1970-06       Impact factor: 22.113

6.  Transforming growth factor-beta1 (TGF-beta1) induces thrombopoietin from bone marrow stromal cells, which stimulates the expression of TGF-beta receptor on megakaryocytes and, in turn, renders them susceptible to suppression by TGF-beta itself with high specificity.

Authors:  S Sakamaki; Y Hirayama; T Matsunaga; H Kuroda; T Kusakabe; T Akiyama; Y Konuma; K Sasaki; N Tsuji; T Okamoto; M Kobune; K Kogawa; J Kato; R Takimoto; R Koyama; Y Niitsu
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

7.  Type beta transforming growth factor is a potent inhibitor of murine megakaryocytopoiesis in vitro.

Authors:  T Ishibashi; S L Miller; S A Burstein
Journal:  Blood       Date:  1987-06       Impact factor: 22.113

8.  MCP-1, not MIP-1alpha, is the endogenous chemokine that cooperates with TGF-beta to inhibit the cycling of primitive normal but not leukemic (CML) progenitors in long-term human marrow cultures.

Authors:  J D Cashman; C J Eaves; A H Sarris; A C Eaves
Journal:  Blood       Date:  1998-10-01       Impact factor: 22.113

9.  Transforming growth factor beta 1 systemically modulates granuloid, erythroid, lymphoid, and thrombocytic cells in mice.

Authors:  J A Carlino; H R Higley; J R Creson; P D Avis; Y Ogawa; L R Ellingsworth
Journal:  Exp Hematol       Date:  1992-09       Impact factor: 3.084

10.  Cytokine mRNA expression of bone marrow stromal cells from patients with aplastic anaemia and myelodysplastic syndrome.

Authors:  Y Hirayama; Y Kohgo; T Matsunaga; S Ohi; S Sakamaki; Y Niitsu
Journal:  Br J Haematol       Date:  1993-12       Impact factor: 6.998

View more
  3 in total

1.  Oscillations in a white blood cell production model with multiple differentiation stages.

Authors:  Franziska Knauer; Thomas Stiehl; Anna Marciniak-Czochra
Journal:  J Math Biol       Date:  2019-09-26       Impact factor: 2.259

2.  Progenitor cell self-renewal and cyclic neutropenia.

Authors:  D Dingli; T Antal; A Traulsen; J M Pacheco
Journal:  Cell Prolif       Date:  2009-04-21       Impact factor: 6.831

3.  In vivo, in vitro, and in silico studies suggest a conserved immune module that regulates malaria parasite transmission from mammals to mosquitoes.

Authors:  Ian Price; Bard Ermentrout; Ruben Zamora; Bo Wang; Nabil Azhar; Qi Mi; Gregory Constantine; James R Faeder; Shirley Luckhart; Yoram Vodovotz
Journal:  J Theor Biol       Date:  2013-06-11       Impact factor: 2.691

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.